Back to top

Jefferies Sticks to Their Buy Rating for Novonesis (0Q4U)

In a report released today, Charles Bentley, CFA from Jefferies maintained a Buy rating on Novonesis (0Q4U – Research Report), with a price target ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)